Press
Keep the bottle upright and press to bring both phases together.
DUAL-CHAMBER FREEZE-DRIED SERUM
02AgeCare ExoSerum Pro
A dual-chamber serum that stores powder and infusion serum separately, then combines them with a press and shake immediately before morning and evening use.
- 0.18 g powder serum
- 3.5 mL EXP infusion serum I
- Made in Japan
PriceSee official sales information
TOKYO DIRECTTracked worldwide delivery from TokyoShipping, duties and returns →
DESIGN CONCEPT
Completedat the moment of use
The freeze-dried powder and infusion serum remain separate until use. The dual-chamber structure distinguishes the time of storage from the moment the serum meets the skin.
- Frequency
- Use morning and evening on its own. In the combined ritual, activate one vial per week and finish it over approximately 3–4 days with AM and PM use.
- Order of use
- Use after toner, following the CELLshot ritual order.
CELLshot / MOTION STUDY
PRODUCT FILM
A serum completed at the moment of use
Stored separately, combined just before use. From activating the dual chamber to smoothing the serum over skin, every movement becomes one continuous ritual.
DUAL-CHAMBER DESIGN
Separated for storageCombined at use
A 0.18 g powder serum and 3.5 mL EXP infusion serum I are stored separately. Keep the bottle upright, press and gently shake to combine, then bring it into your morning and evening serum step.
Shake
Move gently until the powder is fully and evenly dispersed.
AM & PM
Apply to face and neck after toner.
FORMULA & IDENTITY
More than one ingredientA complete serum system
Human Endometrial Stem Cell Exosomes are paired with alpha-arbutin, roselle fruit extract and sodium hyaluronate. Ingredient identity and finished-product evaluation are presented separately.
ATDS
A design approach combining freeze-drying and freshly mixing immediately before use.
70–90 nm
Particle-size specification stated in CELLshot technical materials.
2e10 / vial
Exosome quantity specification per vial stated in CELLshot product materials.
70–90 nm and 2e10 per vial are technical specifications in CELLshot product materials; they are not measurements from HZ-F-2500025.
THE 14-DAY SIGNAL
Three measured signalsat day 14
Before the day-28 endpoint, significant changes were already measured in elasticity, nasolabial-fold wrinkle volume and an acne-area redness-intensity related measure.
Facial elasticity R2
Nasolabial-fold wrinkle volume
Acne-area red-zone a* value
Source: human efficacy evaluation by Hangzhou Huazhuang Technology Co., Ltd., report HZ-F-2500025. Thirty-two participants; 30 valid subjects (1 man, 29 women), ages 30–40; within-subject comparison at D0, D14 and D28. The report does not state frequency of use. Individual results may vary.
28-DAY HERO RESULTS
Elasticity and nasolabial foldsmeasured at day 28
The largest objective change in this evaluation was elasticity R2 below the cheekbone. Nasolabial-fold wrinkle volume was measured by PRIMOS CR three-dimensional imaging.
Facial elasticity R2
44.68 → 60.09
Nasolabial-fold wrinkle volume
98.34 → 79.26 mm³
Source: human efficacy evaluation by Hangzhou Huazhuang Technology Co., Ltd., report HZ-F-2500025. Thirty-two participants; 30 valid subjects (1 man, 29 women), ages 30–40; within-subject comparison at D0, D14 and D28. The report does not state frequency of use. Individual results may vary.
REDNESS-RELATED SIGNALS
Two redness-related measuresat day 28
The acne area and overall face were measured separately through red-zone a* values related to redness intensity. These results do not indicate treatment of acne or inflammation.
Acne-area red-zone a* value
19.26 → 16.09
Facial red-zone a* value
19.17 → 16.80
Source: human efficacy evaluation by Hangzhou Huazhuang Technology Co., Ltd., report HZ-F-2500025. Thirty-two participants; 30 valid subjects (1 man, 29 women), ages 30–40; within-subject comparison at D0, D14 and D28. The report does not state frequency of use. Individual results may vary.
USER EXPERIENCE
Six experience statements100% agreement at day 28
Alongside instrumental measurements, 30 valid subjects assessed their own experience. These are subjective questionnaire results, not objective efficacy rates.
Dryness & tightness
Dryness, tightness, flaking and dry itch felt relieved.
Discomfort
Stinging, itching, heat and redness-related discomfort felt relieved.
Look of wrinkles
Wrinkles appeared less noticeable and their progression felt slower.
Softness & firmness
Skin felt softer, more supple and firmer.
HZ-F-2500025, N=30 valid subjects. At D28, combined scores of 4–6 reached 100% for all six statements. No adverse reactions were observed during the study; this applies only to the test conditions and does not guarantee the absence of reactions for every user.
HOW TO USE
6 steps
Follow the numbered images in order. Refer to the product packaging and enclosed instructions for pressure, mixing time and storage after activation.
- 01
After cleansing, prepare skin with toner
- 02
Keep the bottle upright and push the base upward to connect both phases
- 03
Gently shake or roll until the powder is evenly dispersed
- 04
Attach the supplied dropper
- 05
Draw up an appropriate amount
- 06
Smooth over face and neck, press gently and use morning and evening
FORMULA & TRANSPARENCY
Formula,
clearly presented
Full ingredients＋
Water, Butylene Glycol, Alpha-Arbutin, Hibiscus Sabdariffa Fruit Extract, Glycerin, Sodium Hyaluronate, Erythritol, Pentylene Glycol, Glyceryl Caprylate, Phenoxyethanol, Human Endometrial Stem Cell Exosomes
Use guidance＋
Observe the skin carefully for any abnormality during use. Refer to the product packaging and enclosed instructions for storage conditions and use period after activation.